To read the full story, subscribe or sign in.

Cerus Endovascular wins breakthrough status for brain aneurysm treatment

Feb. 11, 2021

The U.S. FDA has granted breakthrough device designation to Cerus Endovascular Ltd. for its Contour neurovascular system for the treatment of intracranial aneurysms. The company is targeting the second or third quarter of this year for the start of its IDE clinical trial.

BioWorld MedTech Regulatory Cardiovascular Neurology/Psychiatric FDA

Free access to BioWorld coronavirus articles

BioWorld

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

Today's news in brief

BioWorld

BioWorld briefs for April 12.

Somalogic to merge with CM Life Sciences II SPAC, as trendy IPO path continues

BioWorld MedTech

Somalogic Inc. has agreed to go public via a merger with blank-check company CM Life Sciences II. Upon closing, CMLS II – a special purpose acquisition company...

Today's news in brief

BioWorld MedTech

BioWorld MedTech's briefs for April 12.

Global cases rise, but more weapons advance to combat COVID-19

BioWorld

As COVID-19 vaccinations continue to roll out, momentum builds with strong phase III data for what could become the fourth and fifth walls of defense in the U.S.